
Please try another search
Oncoclínicas do Brasil Serviços Médicos S.A. provides healthcare services focused on oncology, hematology, and radiotherapy in Latin America. It offers diagnosis and treatment services, such as pathological analysis, cryotherapy, palliative care, delife, hilotherapy, molecular journey, laser therapy, integrative medicine, myelogram-bone marrow biopsy, OC care line, OC precision medicine, oncoACCESS, survivorship, telemedicine, genetic testing, personalized medicine and individualized treatment, and veinviewer. The company also provides services in the areas of chemotherapy, hormone therapy, molecular target drugs, immunotherapy, bone marrow transplant, catheter salinization and heparinization, and non-oncological infusions. It has collaboration with MGI Tech Co., Ltd. to accelerates the laboratory advancements in genomic medicine. The company was founded in 2010 and is based in São Paulo, Brazil.
Name | Age | Since | Title |
---|---|---|---|
Marcus Vinicius Dias Severini | - | 2023 | Fiscal Council Member |
Renato Fairbanks Nascimbeni de Sá e Silva Ribeiro | - | 2024 | Member of Fiscal Council |
David Castelblanco | - | - | Chairman |
Bruno Lemos Ferrari | - | 2010 | Vice Chairman & CEO |
Flavia Maria Bittencourt | 54 | - | Board Member |
Clarissa Maria de Cerqueira Mathias | - | - | Board Member |
Marcus Vinicius Dias Severini | 66 | 2023 | President of the Fiscal Council |
Eric P. Winer | - | 2022 | Director |
Allen Mc Michael Gibson | - | - | Board Member |
Marcelo del Vigna | - | 2022 | Independent Director |
Joao Carlos Figueiredo Padin | - | 2024 | Chief Strategy Officer & Board Member |
Reginaldo Ferreira Alexandre | 66 | 2024 | Member of Fiscal Council |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review